Wall Street News Alert Announces Investment Opinion: Calculate Risk.

Business Editors

NOTE TO EDITORS: The following is an investment opinion issued

by Wall Street Capital Funding LLC 

WESTON, Fla.--(BUSINESS WIRE)--Feb. 5, 2002

Keep an eye on AMDL, Inc. (AMEX:ADL), the company is the first to market its breakthrough, DR-70 cancer detection blood test in Canada. In the latest clinical trials of DR-70, in over 95% of the time when there was a positive DR-70 reading the patient had or was developing cancer! The Canadian approval hopefully brings FDA approval one step closer. AMDL's work in gene therapy provides even greater potential. In a pre-clinical study mice were injected with cancer. The control group (non-treated) all died of cancer. The group treated with AMDL's combination gene therapy all (100%) survived at the end of the three month trial period. Valuations on companies in this type market improve, often dramatically, as they enter new clinical phases and AMDL is advancing through the clinical trial process on several fronts. The DR-70 could be a breakthrough product in a huge market desperate for breakthroughs. Once approved, the product will add an instant revenue boost. Other active stocks on Monday were: Enterasys Networks Inc. (NYSE:ETS) down 61% to $4.20, on 36 million shares traded, Priceline.com Inc. (Nasdaq:PCLN), down 23% on recent news, Palm, Inc. (Nasdaq:PALM), down 29 cents to $3.31, Durban Roodepoort Deep Lt (Nasdaq:DROOY) up 37% to $2.76 on high volume.

"It is a well known fact that if you want your portfolios to go up, you need to include risk in the formula. The problem is, how much risk can you handle, and what is the right risk for you? There are many mathematical formulas that have this risk/reward ratio based many factors, namely the percentage of your portfolio you are willing to allot to risk, your age, the amount of time you have to spend in the market (versus let's say the amount of years before you retire, etc.). Over a long period of time, 20-30 years, risk and return have a less volatility factor. " Stated Sonja Rudd. More at http://www.WallStreetNewsAlert.com.

Verify all claims and do your own due diligence. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. WSCF is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. The companies that are discussed in this opinion have not approved the statements made in this opinion. WSCF is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained in WSCF profiles is provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks. WSCF has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. (Eighteen Thousand dollars USD for AMDL, Inc. (AMEX:ADL). WSCF intends to sell its shares. WSCF may sell its shares for less than the target price given in its opinions. WSCF will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision.